title: Antihypertensive Therapies and Cognitive Function: a Review.
abstract: Increasing life expectancy has made old age-related health problems like dementia and cognitive decline more prevalent, and these are rapidly becoming important causes of disability and poor quality of life, causing significant add-ons to health-care costs worldwide. Hypertension is the most important modifiable vascular risk factor for the development and progression of both cognitive decline and dementia. In many observational and randomized studies, antihypertensive therapies have been shown to be beneficial in slowing cognitive decline. However, due to observed discrepancies by these studies, there is a lack of consensus on the best antihypertensive strategy for the prevention or slowing of cognitive decline. It is also not clear whether the beneficial effect of antihypertensive therapy is due to the use of a specific class of agents or combination therapy. Thus, we present a comprehensive review of overall antihypertensive therapies and cognition and of the individual antihypertensive therapy classes with their specific protective mechanisms and available clinical evidence behind their effect on cognitive function.
authors: Department of Cardiology, Mount Sinai Medical Center, Columbia University, 4300 Alton Rd, Suite 2070, Miami Beach, FL, 33140, USA, kherada.1@gmail.com.
authors: Nisharahmed
authors: N
authors: Kherada
authors: Todd
authors: T
authors: Heimowitz
authors: Clive
authors: C
authors: Rosendorff
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003071:Cognition; D003072:Cognition Disorders / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D011788:Quality of Life; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents